4482 -- Coordinating Substance Use and Homelessness Care Act of 2022 | Poliscope

Coordinating Substance Use and Homelessness Care Act of 2022

4482

117th Congress

Housing and Community Development

In Committee

Legislative Progress

✓

Introduced

Committee

Floor Vote

Other Chamber

Enacted

Introduced

June 23, 2022

Latest Action

June 23, 2022

Primary Sponsor

Alex PadillaDemocratic(CA)

Momentum (last 30 days)

score

0 actions · 0 new cosponsors · 0 votes

Speed vs cohort

0pct

0d open

vs 5,357 other S bills in the 117th — cohort avg 38d

Summary

Coordinating Substance Use and Homelessness Care Act of 2022 This bill requires the Department of Housing and Urban Development to award competitive grants to improve coordination of health care and homelessness services for individuals who are homeless, have significant behavioral health issues (e.g., substance use disorders), and voluntarily seek assistance. Entities eligible for these grants include local and tribal governments, public housing agencies that administer housing choice vouchers, and certain nonprofits.

Lobbying filings that explicitly cite this bill (1)

These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.

Filing registrants (1)

END SUD, INC. DBA END SUBSTANCE USE DISORDER (1)

END SUD, INC. DBA END SUBSTANCE USE DISORDERclient→END SUD, INC. DBA END SUBSTANCE USE DISORDER

2022 · second_quarter · Alcohol and Drug Abuse

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Advocated on issues related to H.R. 1384/S. 445, Mainstreaming Addiction Treatment Act, All Provisions; H.R. 7666 Restoring Hope for Mental Health and Well-Being Act of 2022, section 262 regarding the amendment of the Controlled Substances Act related to maintenance and detoxification treatment; S. 4482, Coordinating Substance Use and Homelessness Care Act of 2022, All Provisions; S. 4301 Substance Use Prevention, Treatment, and Recovery Act, All Provisions; U.S. Drug Enforcement Agency, request relating to enforcement of pharmacies and wholesalers providing buprenorphine for opioid use disorder; Centers for Medicaid and Medicare Services, policy related to ensuring in-network access to treatment for opioid use disorders under Medicare advantage plans; Centers for Disease Control, Infectious Disease and Opioid Epidemic program, Fiscal Year 2023 budget, provisions related to syringe service programs